Novel face of microRNA-155

4Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Jiang and Aguiar1 present a novel mechanism in diffuse large B-cell lymphoma (DLBCL) cell lines by which microRNA (miR)-155 deregulate the crucial retinoblastoma protein (RB)/E2F cascade by repressing SMAD5. The resulting hyperphosphorylated RB is inactive and mediates unrestricted cell-cycle progression. Conversely, they demonstrate in mature B lymphocytes from miR-155 knockout (KO) mice elevated SMAD5 levels accompanied by a hypophosphorylated RB state and a more pronounced cell-cycle arrest. This might contribute to the reduced numbers of germinal center B cells and impaired T cell-dependent antibody response found in these mice. © 2014 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Neumeister, P., & Sill, H. (2014). Novel face of microRNA-155. Blood, 123(1), 5–7. https://doi.org/10.1182/blood-2013-11-534107

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free